AdvisorShares Investments LLC Takes $418,000 Position in Cabot Co. (NYSE:CBT)

AdvisorShares Investments LLC bought a new position in shares of Cabot Co. (NYSE:CBT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,580 shares of the specialty chemicals company's stock, valued at approximately $418,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Barclays PLC lifted its holdings in shares of Cabot by 103.9% in the 3rd quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company's stock valued at $12,699,000 after buying an additional 57,907 shares during the period. World Investment Advisors LLC acquired a new position in Cabot in the third quarter valued at approximately $3,161,000. Wilmington Savings Fund Society FSB purchased a new stake in Cabot in the 3rd quarter worth approximately $1,651,000. Tidal Investments LLC grew its stake in shares of Cabot by 2.9% during the 3rd quarter. Tidal Investments LLC now owns 11,917 shares of the specialty chemicals company's stock worth $1,332,000 after purchasing an additional 340 shares during the period. Finally, Franklin Resources Inc. purchased a new position in shares of Cabot during the 3rd quarter valued at approximately $654,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have issued reports on CBT. Mizuho lowered their price target on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research report on Tuesday, January 7th. UBS Group dropped their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. StockNews.com raised shares of Cabot from a "hold" rating to a "buy" rating in a report on Thursday, April 17th. Finally, JPMorgan Chase & Co. cut their target price on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research note on Friday, February 21st.

Cabot Trading Down 0.4 %

Shares of CBT stock opened at $78.68 on Wednesday. Cabot Co. has a fifty-two week low of $73.63 and a fifty-two week high of $117.46. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. The stock's fifty day moving average is $81.60 and its two-hundred day moving average is $93.24. The firm has a market capitalization of $4.27 billion, a P/E ratio of 10.45, a PEG ratio of 0.74 and a beta of 1.04.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Research analysts expect that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.